| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1126824A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 08/29/2001 | EP0831782A4 Methods and system for processing dispersible fine powders |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | EP0618925B1 Antisense oligonucleotides |
| 08/29/2001 | CN1310765A Mutant herpes simplex viruses and uses thereof |
| 08/29/2001 | CN1310632A Stable gene preparations |
| 08/29/2001 | CN1310231A Application of recombinant adenovirus related virus containing growth hormone gene or related gene in promoting pig's growth and improving meat quality |
| 08/29/2001 | CN1070198C Isolated nucleic acid molecule of coded tumor rejection antigen precursor DAGE and its application |
| 08/29/2001 | CA2335436A1 Novel core 2 beta-1,6-n-acetylglycosaminyl transferase gene |
| 08/28/2001 | US6281371 Lipopolyamines, and the preparation and use thereof |
| 08/28/2001 | US6281330 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 08/28/2001 | US6281200 Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2 |
| 08/28/2001 | US6281010 Gene expression, engineering; packaging transgene; genetic disorders |
| 08/28/2001 | US6281009 Gene therapy; nervous system, brain disorders; cancer |
| 08/28/2001 | US6281005 Monitor coupled to immersible probe to measure batch solution; data processing; genetic engineering |
| 08/28/2001 | US6281000 Dna fragment cloning into genome of recombinant adenoviral plasmid vector; human gene therapy |
| 08/28/2001 | US6280994 Zace 1: a human metalloenzyme |
| 08/28/2001 | US6280978 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280969 Growth arrest homeobox gene |
| 08/28/2001 | US6280956 Antibodies to bladder cancer nuclear matrix proteins and their use |
| 08/28/2001 | US6280739 Method of inhibiting angiogenesis using secreted proteins |
| 08/28/2001 | US6280735 Polypeptides of riboflavin specific deaminase family |
| 08/28/2001 | US6280724 Composition and method for preserving progenitor cells |
| 08/28/2001 | CA2317003A1 Gene expression potentiator |
| 08/23/2001 | WO2001061025A1 Method for increasing the gene expression of transfected genes |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061005A2 Molecules of the pyrin domain protein family and uses thereof |
| 08/23/2001 | WO2001060998A2 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | WO2001060996A1 Method of controlling telomere length |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060990A2 Sphingosine kinases |
| 08/23/2001 | WO2001060983A2 Treatment for bone disorders |
| 08/23/2001 | WO2001060975A2 Gene disruption methodologies in fungi for drug target discovery |
| 08/23/2001 | WO2001060866A1 Anti-viral conjugate comprising a factor allowing the translocation of a protein across a cell membrane and comprising a single-chain antibody fragment directed against a viral protein |
| 08/23/2001 | WO2001060857A2 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | WO2001060847A2 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060794A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 08/23/2001 | WO2001060415A1 Methods and compositions for gene delivery |
| 08/23/2001 | WO2001060414A2 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | WO2001060413A2 Recombinant vector expressing a beta2-adrenergic receptor and use in treating airway and vascular diseases |
| 08/23/2001 | WO2001060403A1 Gm-negative ehv-mutants |
| 08/23/2001 | WO2001060400A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 08/23/2001 | WO2001060377A2 Methods for treatment of lysosomal storage diseases using biphosphonates |
| 08/23/2001 | WO2001060350A2 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 08/23/2001 | WO2001025422A3 Antisense compositions and cancer-treatment methods |
| 08/23/2001 | WO2001024764A3 Cell targeting compositions and methods of using the same |
| 08/23/2001 | WO2001023522A3 Compositions and methods for p53-mediated repression of gene expression |
| 08/23/2001 | WO2001016326A3 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (PFEMP1) that mediates adhesion to chondroitin sulfate A |
| 08/23/2001 | WO2001012775A3 25 human secreted proteins |
| 08/23/2001 | WO2001012215A3 Protective antigen of Epstein barr virus |
| 08/23/2001 | WO2001011031A3 Gene transfer to pancreatic beta cells for prevention of islet dysfunction |
| 08/23/2001 | WO2001010907A3 Therapeutic polypeptides and methods for using same |
| 08/23/2001 | WO2001007637A3 Conditionally controlled, attenuated HIV vaccine |
| 08/23/2001 | WO2001007611A3 Novel polynucleotides and method for the use thereof |
| 08/23/2001 | WO2001000860A3 Prolactin-inducible mammary specific promoter |
| 08/23/2001 | WO2000077177A3 Isolation of a human retrovirus |
| 08/23/2001 | WO1999047639A3 Staphylococcus aureus genes and polypeptides |
| 08/23/2001 | US20010016952 Pathogenesis of cardiomyopathy |
| 08/23/2001 | US20010016647 29 human secreted proteins |
| 08/23/2001 | US20010016575 Antisense modulation of human MDM2 expression |
| 08/23/2001 | US20010016355 Genetic engineering |
| 08/23/2001 | US20010016352 Oligonucleotides; detection cancer |
| 08/23/2001 | US20010016339 Pancreatic polypeptide |
| 08/23/2001 | US20010016336 Genetic engineered polypeptide |
| 08/23/2001 | US20010016319 Cloning of a novel G-protein coupled 7TM Receptor |
| 08/23/2001 | US20010016199 Alphavirus RNA replicon systems |
| 08/23/2001 | US20010016193 Methods of altering cardiac cell phenotype |
| 08/23/2001 | DE10006033A1 New pharmaceutical for immunization against a carcinoma and its preliminary stages contains a cell cycle regulatory protein, particularly the cyclin-dependent kinase inhibitor p16 |
| 08/23/2001 | CA2402148A1 Novel sphingosine kinases |
| 08/23/2001 | CA2400634A1 Genetic modification of the lung as a portal for gene delivery |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400360A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400332A1 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | CA2400263A1 Method of controlling telomere length |
| 08/23/2001 | CA2400256A1 Compositions useful for regulating parkin gene activity |
| 08/23/2001 | CA2400206A1 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 08/23/2001 | CA2400110A1 Method for increasing the gene expression of transfected genes using carnitine |
| 08/23/2001 | CA2400034A1 Human kinases |
| 08/23/2001 | CA2399705A1 Treatment for bone disorders |
| 08/23/2001 | CA2398945A1 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | CA2398872A1 Avirulent, immunogenic flavivirus chimeras |
| 08/23/2001 | CA2398861A1 Gene disruption methodologies for drug target discovery |
| 08/23/2001 | CA2337574A1 Hematopoietic stem cell expansion enhancing factor and method of use |
| 08/22/2001 | EP1126034A2 Coding sequences of the human BRCA1 gene |
| 08/22/2001 | EP1126028A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 08/22/2001 | EP1126025A2 Oligonucleotide modulation of protein kinase C |
| 08/22/2001 | EP1125947A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 08/22/2001 | EP1124983A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
| 08/22/2001 | EP1124978A1 AN UNUSUAL RETROTRANSPOSON FROM THE YEAST $i(CANDIDA ALBICANS) |
| 08/22/2001 | EP1124977A1 Modified adenoviral fibre and uses thereof |
| 08/22/2001 | EP1124975A1 A myeloid precursor cell useful for gene therapy and for modulation of immune responses |
| 08/22/2001 | EP1124966A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124958A2 Corticosteroid synthesis-associated genes |